Renascience, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Wakamoto Pharmaceutical Co., Ltd.

Taiko Pharmaceutical Co., Ltd.

Solasia Pharma KK

BrightPath Biotherapeutics Co., Ltd.

Nippon Chemiphar Co., Ltd.

Healios KK

Fuso Pharmaceutical Industries Ltd.

RaQualia Pharma, Inc.

Renascience, Inc.

SymBio Pharmaceuticals Ltd.

CanBas Co., Ltd.

Why is Renascience, Inc. ?

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Operating profit has grown by an annual rate 4.82% of over the last 5 years

NET SALES(Q) At JPY 10 MM has Fallen at -75%
RAW MATERIAL COST(Y) Grown by 13.22% (YoY)
OPERATING PROFIT(Q) Lowest at JPY -102.27 MM

With ROE of -10.23%, it has a attractive valuation with a 13.77 Price to Book Value

Over the past year, while the stock has generated a return of 22.42%, its profits have risen by 30.7%

Underperformed the market in the last 1 year

The stock has generated a return of 22.42% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 38.59%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Renascience, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Renascience, Inc.

22.42%

3.05

99.74%

Japan Nikkei 225

38.59%

1.45

26.59%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.61%

EBIT Growth (5y)

4.82%

EBIT to Interest (avg)

-238.51

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.05

Sales to Capital Employed (avg)

0.08

Tax Ratio

21.10%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

13.77

EV to EBIT

-122.43

EV to EBITDA

-122.48

EV to Capital Employed

-274.84

EV to Sales

165.00

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-10.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at JPY -106.38 MM

-26What is not working for the Company

NET SALES(Q)

At JPY 10 MM has Fallen at -75%

RAW MATERIAL COST(Y)

Grown by 13.22% (YoY

OPERATING PROFIT(Q)

Lowest at JPY -102.27 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -1,022.74 %

PRE-TAX PROFIT(Q)

Lowest at JPY -66.63 MM

NET PROFIT(Q)

Lowest at JPY -66.88 MM

EPS(Q)

Lowest at JPY -5.26

Here's what is not working for Renascience, Inc.

Net Sales

At JPY 10 MM has Fallen at -75%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (JPY MM)

Pre-Tax Profit

At JPY -66.63 MM has Fallen at -82.75%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit

At JPY -66.88 MM has Fallen at -81.01%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (JPY MM)

Operating Profit

Lowest at JPY -102.27 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin

Lowest at -1,022.74 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at JPY -66.63 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Lowest at JPY -66.88 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS

Lowest at JPY -5.26

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Raw Material Cost

Grown by 13.22% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales